Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.99 billion.
Market Cap
1.13T
Revenue
110.99B
Profits
-39.81B
PE Ratio
n/a
Profit Margin
-35.87%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.71B | 0.98% | 1,121,185 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.94B | 3.02% | 1,096,638 | 14.92B |
| 3 | ARGX | argenx SE | 48.73B | 0.73% | 410,925 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.29B | 2.76% | 2,192,119 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.81B | 1.54% | 134,728 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.31B | 2.54% | 2,314,566 | - |
| 7 | RPRX | Royalty Pharma plc | 29.69B | 1.21% | 4,140,151 | 2.38B |
| 8 | INSM | Insmed Incorporated | 29.43B | 0.96% | 1,336,985 | 606.42M |
| 9 | BNTX | BioNTech SE | 26.16B | 1.85% | 707,120 | 3.37B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.42B | 3.67% | 7,014,634 | 13.31M |
| 11 | INCY | Incyte Corporation | 19.03B | -3.86% | 2,409,863 | 5.36B |
| 12 | MRNA | Moderna, Inc. | 18.22B | 0.48% | 6,066,051 | 1.94B |
| 13 | SMMT | Summit Therapeutics Inc. | 16.65B | 3.02% | 5,658,229 | - |
| 14 | GMAB | Genmab A/S | 16.28B | 1.57% | 1,322,635 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 14.17B | 4.13% | 576,920 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.79B | 0.24% | 2,675,053 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.50B | 1.55% | 542,828 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.36B | -0.09% | 2,430,345 | 1.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.87B | -0.23% | 227,358 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.29B | -0.51% | 2,153,270 | 2.32B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 10.63B | 12.94% | 2,798,892 | 638.50M |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.42B | -0.55% | 1,594,976 | 3.22B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.29B | 4.18% | 1,202,023 | 1.09B |
| 24 | ABVX | ABIVAX Société Anonyme | 8.96B | 10.49% | 1,200,840 | 5.37M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | -1.35% | 780,348 | 7.46M |
| 26 | TECH | Bio-Techne Corporation | 8.65B | 6.49% | 3,522,922 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.26B | -0.14% | 1,904,375 | - |
| 28 | CYTK | Cytokinetics, Incorporated | 7.95B | 7.37% | 2,723,470 | 88.04M |
| 29 | NUVL | Nuvalent, Inc. | 7.88B | 1.19% | 476,135 | - |
| 30 | KRYS | Krystal Biotech, Inc. | 7.72B | 0.89% | 181,329 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.54B | 0.95% | 1,159,984 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.33B | 2.01% | 6,536,515 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.62B | -0.54% | 751,424 | 51.48M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 6.42B | 3.56% | 1,044,357 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.32B | 0.46% | 577,600 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.26B | 3.02% | 58,521 | - |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.12B | 1.05% | 520,422 | - |
| 38 | COGT | Cogent Biosciences, Inc. | 6.12B | -0.22% | 1,321,055 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.11B | 0.02% | 1,782,567 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.08% | 3,031,374 | 15.00M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.93B | 3.30% | 654,664 | 521.31M |
| 42 | CELC | Celcuity Inc. | 5.87B | 1.97% | 675,376 | - |
| 43 | CGON | CG Oncology, Inc. | 5.64B | 3.07% | 709,529 | 4.04M |
| 44 | SRRK | Scholar Rock Holding Corporation | 5.56B | 0.67% | 872,948 | - |
| 45 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.56B | -0.93% | 528,547 | 189.76M |
| 46 | IMVT | Immunovant, Inc. | 5.52B | 0.72% | 2,059,345 | - |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.42B | 0.52% | 1,345,956 | 7.50M |
| 48 | PTCT | PTC Therapeutics, Inc. | 5.39B | 0.79% | 1,171,506 | 1.73B |
| 49 | CAI | Caris Life Sciences, Inc. | 5.37B | 6.92% | 1,666,512 | 812.03M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | - | 3,019,260 | 1.00B |
| 51 | CRSP | CRISPR Therapeutics AG | 5.04B | 3.21% | 1,300,058 | 3.51M |
| 52 | CORT | Corcept Therapeutics Incorporated | 4.99B | -0.15% | 1,233,102 | 769.10M |
| 53 | TGTX | TG Therapeutics, Inc. | 4.99B | 0.60% | 1,384,132 | 616.29M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.78B | 5.15% | 428,092 | 2.04M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 4.60B | 2.04% | 265,481 | 268.09M |
| 56 | LEGN | Legend Biotech Corporation | 4.35B | 3.29% | 1,079,099 | 1.03B |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.06B | 0.88% | 852,918 | 7.70M |
| 58 | TVTX | Travere Therapeutics, Inc. | 3.89B | 5.04% | 2,519,589 | 490.73M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 3.84B | 1.13% | 1,734,912 | 1.07B |
| 60 | MANE | Veradermics, Incorporated | 3.70B | -7.09% | 1,768,763 | - |
| 61 | TLX | Telix Pharmaceuticals Limited | 3.66B | 5.47% | 226,385 | 803.79M |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.61B | -0.48% | 6,609,382 | - |
| 63 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.44B | -0.46% | 2,091,146 | 588.99M |
| 64 | ORKA | Oruka Therapeutics, Inc. | 3.43B | 0.46% | 3,976,842 | - |
| 65 | EWTX | Edgewise Therapeutics, Inc. | 3.33B | 1.67% | 1,136,387 | - |
| 66 | ERAS | Erasca, Inc. | 3.31B | 16.90% | 12,711,124 | - |
| 67 | NAMS | NewAmsterdam Pharma Company N.V. | 3.28B | 0.46% | 593,524 | 22.50M |
| 68 | KLRA | Kailera Therapeutics, Inc. | 3.24B | 0.97% | 462,551 | - |
| 69 | RCUS | Arcus Biosciences, Inc. | 3.20B | 5.68% | 1,163,504 | 247.00M |
| 70 | ALMS | Alumis Inc. | 3.14B | 7.86% | 1,011,930 | 24.05M |
| 71 | TNGX | Tango Therapeutics, Inc. | 3.12B | -1.99% | 3,784,324 | 62.38M |
| 72 | BEAM | Beam Therapeutics Inc. | 3.04B | 3.23% | 1,435,591 | 139.74M |
| 73 | DNLI | Denali Therapeutics Inc. | 2.97B | 0.65% | 2,866,552 | - |
| 74 | GPCR | Structure Therapeutics Inc. | 2.95B | 0.19% | 1,102,222 | - |
| 75 | ARQT | Arcutis Biotherapeutics, Inc. | 2.90B | 3.80% | 1,418,645 | 376.07M |
| 76 | DYN | Dyne Therapeutics, Inc. | 2.90B | 0.80% | 1,035,460 | - |
| 77 | NKTR | Nektar Therapeutics | 2.87B | 2.21% | 764,011 | 55.23M |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.08% | 1,073,972 | 190.41M |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | 4.85% | 791,951 | 451.36M |
| 80 | KOD | Kodiak Sciences Inc. | 2.70B | -0.44% | 432,625 | - |
| 81 | IMNM | Immunome, Inc. | 2.60B | -0.04% | 1,408,584 | 6.94M |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.58B | 2.30% | 647,950 | 1.55M |
| 83 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | 3.74% | 946,678 | 218.71M |
| 84 | VERA | Vera Therapeutics, Inc. | 2.55B | -0.64% | 932,212 | - |
| 85 | IRON | Disc Medicine, Inc. | 2.52B | -0.03% | 424,058 | - |
| 86 | ELVN | Enliven Therapeutics, Inc. | 2.47B | -2.76% | 821,926 | - |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.45B | 3.10% | 2,389,759 | 15.36M |
| 88 | ZLAB | Zai Lab Limited | 2.43B | 4.29% | 266,450 | 460.16M |
| 89 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42B | 2.11% | 1,790,725 | 673.00M |
| 90 | ADMA | ADMA Biologics, Inc. | 2.38B | -3.30% | 7,315,716 | 510.17M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.20B | 4.26% | 698,316 | - |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.19B | 1.02% | 1,748,369 | 2.20B |
| 93 | DFTX | Definium Therapeutics, Inc. | 2.18B | 6.78% | 1,579,641 | - |
| 94 | ADPT | Adaptive Biotechnologies Corporation | 2.17B | 4.21% | 1,189,355 | 276.98M |
| 95 | AAPG | Ascentage Pharma Group International | 2.10B | 1.76% | 713 | 82.08M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.07B | 2.84% | 1,556,639 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.04B | 1.74% | 2,761,248 | 51.95M |
| 98 | STOK | Stoke Therapeutics, Inc. | 2.04B | 0.93% | 476,008 | 184.42M |
| 99 | ZYME | Zymeworks Inc. | 2.03B | -1.04% | 482,668 | 105.97M |
| 100 | PHVS | Pharvaris N.V. | 2.03B | 3.96% | 739,714 | - |
| 101 | AUPH | Aurinia Pharmaceuticals Inc. | 2.00B | 0.69% | 1,193,895 | 283.06M |
| 102 | MESO | Mesoblast Limited | 1.97B | 0.77% | 123,123 | 65.38M |
| 103 | CAPR | Capricor Therapeutics, Inc. | 1.94B | 3.45% | 837,871 | 11.13M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 1.93B | -0.43% | 2,858,338 | - |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | 3.88% | 1,663,349 | 217.17M |
| 106 | ANAB | AnaptysBio, Inc. | 1.89B | 5.44% | 517,919 | 234.60M |
| 107 | INBX | Inhibrx Biosciences, Inc. | 1.89B | 3.52% | 539,980 | 1.30M |
| 108 | GLPG | Galapagos NV | 1.87B | -0.11% | 189,325 | 1.31B |
| 109 | PVLA | Palvella Therapeutics, Inc. | 1.84B | 4.80% | 138,850 | - |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | 1.91% | 1,907,670 | 9.77M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.83B | 4.85% | 13,200,200 | 74.68M |
| 112 | HRMY | Harmony Biosciences Holdings, Inc. | 1.81B | 0.68% | 475,594 | 868.45M |
| 113 | VCEL | Vericel Corporation | 1.77B | 3.89% | 761,360 | 276.26M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.75B | 3.39% | 241,674 | - |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.73B | 0.54% | 840,241 | 71.78M |
| 116 | INVA | Innoviva, Inc. | 1.70B | -0.26% | 626,100 | 411.33M |
| 117 | VIR | Vir Biotechnology, Inc. | 1.65B | 1.34% | 1,167,599 | 68.56M |
| 118 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | -0.18% | 1,306,003 | 66.05M |
| 119 | NBTX | Nanobiotix S.A. | 1.63B | 4.94% | 100,862 | 38.27M |
| 120 | OCS | Oculis Holding AG | 1.63B | 3.89% | 1,347,032 | 1.51M |
| 121 | GENB | Generate Biomedicines, Inc. | 1.61B | 2.02% | 202,262 | 31.89M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.59B | 8.27% | 13,108,675 | 67.67M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.58B | 0.39% | 347,896 | - |
| 124 | ARDX | Ardelyx, Inc. | 1.55B | 5.32% | 8,457,282 | 427.68M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.55B | 7.23% | 204,199 | - |
| 126 | NUVB | Nuvation Bio Inc. | 1.55B | 2.53% | 4,805,739 | 62.90M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | 2.30% | 731,222 | 123.67M |
| 128 | ATAI | AtaiBeckley Inc. | 1.53B | 0.97% | 4,193,095 | 4.09M |
| 129 | IMTX | Immatics N.V. | 1.47B | -1.87% | 701,985 | 56.67M |
| 130 | PGEN | Precigen, Inc. | 1.47B | 0.97% | 2,515,682 | 9.68M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.47B | 3.50% | 629,666 | 2.50M |
| 132 | MPLT | MapLight Therapeutics, Inc. | 1.44B | 5.22% | 191,907 | - |
| 133 | BHVN | Biohaven Ltd. | 1.44B | 4.24% | 1,569,244 | - |
| 134 | MBX | MBX Biosciences, Inc. | 1.44B | 5.63% | 299,983 | - |
| 135 | IMCR | Immunocore Holdings plc | 1.42B | -0.04% | 488,649 | 400.02M |
| 136 | BCAX | Bicara Therapeutics Inc. | 1.41B | 1.41% | 432,353 | - |
| 137 | VRDN | Viridian Therapeutics, Inc. | 1.39B | 1.35% | 1,249,739 | 70.85M |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 1.38B | 1.51% | 16,314,672 | 263.50M |
| 139 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 3.46% | 526,320 | - |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 1.37B | -0.04% | 13,634,080 | 73.62M |
| 141 | WVE | Wave Life Sciences Ltd. | 1.36B | 0.14% | 3,384,569 | 71.80M |
| 142 | SVRA | Savara Inc. | 1.33B | 8.04% | 2,197,302 | - |
| 143 | NVAX | Novavax, Inc. | 1.29B | -0.56% | 2,817,354 | 1.12B |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.28B | 5.34% | 949,710 | - |
| 145 | GHRS | GH Research PLC | 1.27B | 7.15% | 125,523 | - |
| 146 | DBVT | DBV Technologies S.A. | 1.26B | 3.45% | 243,800 | 5.64M |
| 147 | ABCL | AbCellera Biologics Inc. | 1.26B | 8.64% | 5,991,785 | 75.13M |
| 148 | QURE | uniQure N.V. | 1.26B | 19.25% | 4,437,476 | 16.10M |
| 149 | OLMA | Olema Pharmaceuticals, Inc. | 1.26B | 1.91% | 798,533 | - |
| 150 | AVLN | Avalyn Pharma Inc. | 1.23B | 63.83% | 6,511,988 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.20B | 9.32% | 595,390 | - |
| 152 | PHAR | Pharming Group N.V. | 1.19B | 1.04% | 3,614 | 376.13M |
| 153 | MLTX | MoonLake Immunotherapeutics | 1.17B | 1.68% | 569,056 | - |
| 154 | URGN | UroGen Pharma Ltd. | 1.16B | 2.10% | 409,952 | 109.79M |
| 155 | ZBIO | Zenas BioPharma, Inc. | 1.15B | 10.09% | 686,615 | 10.00M |
| 156 | EYPT | EyePoint, Inc. | 1.10B | 2.64% | 950,103 | 31.37M |
| 157 | FTRE | Fortrea Holdings Inc. | 1.08B | 8.90% | 2,333,387 | 2.72B |
| 158 | SEPN | Septerna, Inc. | 1.07B | 1.32% | 271,906 | 45.95M |
| 159 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | 1.74% | 1,046,162 | 291.85M |
| 160 | OMER | Omeros Corporation | 1.05B | 0.27% | 712,574 | - |
| 161 | IVA | Inventiva S.A. | 1.05B | 3.85% | 157,152 | 7.94M |
| 162 | AKTS | Aktis Oncology, Inc. | 1.04B | 0.16% | 177,547 | 6.50M |
| 163 | ORIC | ORIC Pharmaceuticals, Inc. | 991.54M | 4.66% | 919,795 | - |
| 164 | GERN | Geron Corporation | 986.99M | 1.99% | 11,190,016 | 183.88M |
| 165 | ANNX | Annexon, Inc. | 953.92M | -0.34% | 2,174,818 | - |
| 166 | MRVI | Maravai LifeSciences Holdings, Inc. | 946.01M | 5.75% | 971,416 | 185.74M |
| 167 | CTMX | CytomX Therapeutics, Inc. | 918.67M | 4.20% | 4,340,768 | 76.20M |
| 168 | SLS | SELLAS Life Sciences Group, Inc. | 913.44M | 6.00% | 3,783,610 | - |
| 169 | LBRX | LB Pharmaceuticals Inc | 909.30M | 3.66% | 148,056 | - |
| 170 | ANRO | Alto Neuroscience, Inc. | 899.45M | 5.60% | 336,815 | - |
| 171 | PHAT | Phathom Pharmaceuticals, Inc. | 889.62M | -4.92% | 4,232,294 | 204.89M |
| 172 | SANA | Sana Biotechnology, Inc. | 888.27M | 1.23% | 2,972,384 | - |
| 173 | XNCR | Xencor, Inc. | 874.93M | 2.67% | 460,254 | 125.58M |
| 174 | JANX | Janux Therapeutics, Inc. | 874.15M | 1.84% | 978,661 | 10.00M |
| 175 | MNKD | MannKind Corporation | 873.89M | 2.91% | 3,616,947 | 348.97M |
| 176 | TBPH | Theravance Biopharma, Inc. | 861.99M | 0.42% | 263,997 | 107.46M |
| 177 | DRUG | Bright Minds Biosciences Inc. | 861.94M | -1.30% | 161,431 | - |
| 178 | EVMN | Evommune, Inc. | 857.24M | -0.21% | 426,917 | 13.00M |
| 179 | MGTX | MeiraGTx Holdings plc | 853.38M | 3.02% | 641,842 | 81.39M |
| 180 | DSGN | Design Therapeutics, Inc. | 849.41M | -13.87% | 1,000,167 | - |
| 181 | ABUS | Arbutus Biopharma Corporation | 827.15M | 1.69% | 797,453 | 14.08M |
| 182 | SPRY | ARS Pharmaceuticals, Inc. | 820.20M | 5.36% | 1,357,267 | 84.28M |
| 183 | TRAX | First Tracks Biotherapeutics, Inc. | 808.61M | -1.57% | 391,917 | - |
| 184 | CGEM | Cullinan Therapeutics, Inc. | 789.87M | 1.56% | 380,939 | - |
| 185 | RLMD | Relmada Therapeutics, Inc. | 788.76M | 2.04% | 922,952 | - |
| 186 | KURA | Kura Oncology, Inc. | 783.77M | 0.91% | 774,012 | 67.48M |
| 187 | VOR | Vor Biopharma Inc. | 776.48M | 2.14% | 549,190 | - |
| 188 | ABSI | Absci Corporation | 773.35M | 5.63% | 5,586,884 | 2.80M |
| 189 | TENX | Tenax Therapeutics, Inc. | 771.89M | 2.58% | 510,419 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 766.81M | 3.66% | 56,833 | - |
| 191 | CBIO | Crescent Biopharma, Inc. | 743.33M | 6.83% | 280,026 | 11.88M |
| 192 | DRTS | Alpha Tau Medical Ltd. | 734.00M | 13.16% | 777,149 | - |
| 193 | ALLO | Allogene Therapeutics, Inc. | 732.67M | 0.95% | 5,045,224 | 22.00K |
| 194 | SLDB | Solid Biosciences Inc. | 714.48M | 2.98% | 754,782 | - |
| 195 | GYRE | Gyre Therapeutics, Inc. | 701.29M | 4.49% | 54,472 | 116.59M |
| 196 | LXRX | Lexicon Pharmaceuticals, Inc. | 682.13M | 3.87% | 1,160,392 | 49.80M |
| 197 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.08M | 4.34% | 357,130 | - |
| 198 | FBRX | Forte Biosciences, Inc. | 652.59M | -4.89% | 170,666 | - |
| 199 | ARVN | Arvinas, Inc. | 633.21M | 0.81% | 527,330 | 262.60M |
| 200 | PRME | Prime Medicine, Inc. | 627.97M | 0.42% | 1,558,904 | 4.63M |
| 201 | STRO | Sutro Biopharma, Inc. | 606.72M | 3.48% | 304,836 | 102.48M |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 606.14M | -2.91% | 1,742,365 | 7.83M |
| 203 | ZVRA | Zevra Therapeutics, Inc. | 601.20M | 5.17% | 1,062,487 | 106.47M |
| 204 | PRTA | Prothena Corporation plc | 595.39M | 1.75% | 319,521 | 9.68M |
| 205 | CRMD | CorMedix Inc. | 595.27M | 1.47% | 636,483 | 311.71M |
| 206 | OCGN | Ocugen, Inc. | 585.63M | 2.98% | 4,041,049 | 4.41M |
| 207 | PROK | ProKidney Corp. | 573.73M | 4.40% | 789,749 | 893.00K |
| 208 | ANL | Adlai Nortye Ltd. | 570.80M | 1.28% | 384,416 | 5.00M |
| 209 | STTK | Shattuck Labs, Inc. | 540.41M | 0.85% | 407,109 | 1.00M |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 534.07M | -1.10% | 515,664 | 294.28M |
| 211 | KYTX | Kyverna Therapeutics, Inc. | 532.67M | 4.76% | 929,222 | - |
| 212 | AGMB | AgomAb Therapeutics NV | 528.79M | 1.02% | 47,128 | - |
| 213 | PRLD | Prelude Therapeutics Incorporated | 525.89M | 22.48% | 586,776 | 12.14M |
| 214 | TECX | Tectonic Therapeutic, Inc. | 525.18M | 3.32% | 129,892 | - |
| 215 | EIKN | Eikon Therapeutics, Inc. | 520.54M | 5.54% | 195,655 | - |
| 216 | VALN | Valneva SE | 510.85M | 0.94% | 40,914 | 205.07M |
| 217 | ALT | Altimmune, Inc. | 504.92M | -1.14% | 5,675,475 | 41.00K |
| 218 | UPB | Upstream Bio, Inc. | 499.58M | -0.11% | 395,121 | 2.85M |
| 219 | MDXG | MiMedx Group, Inc. | 499.18M | 8.91% | 3,523,101 | 389.42M |
| 220 | SGMT | Sagimet Biosciences Inc. | 495.87M | -6.63% | 1,158,678 | - |
| 221 | TRDA | Entrada Therapeutics, Inc. | 493.24M | 6.13% | 612,382 | 25.42M |
| 222 | DNA | Ginkgo Bioworks Holdings, Inc. | 492.43M | 12.80% | 1,533,562 | 170.16M |
| 223 | XOMA | XOMA Royalty Corporation | 487.83M | -0.12% | 822,766 | 52.15M |
| 224 | ENGN | enGene Therapeutics Inc. | 487.01M | 3.27% | 155,174 | - |
| 225 | ZURA | Zura Bio Limited | 481.99M | 1.40% | 431,514 | - |
| 226 | EPRX | Eupraxia Pharmaceuticals Inc. | 481.19M | 6.27% | 251,794 | - |
| 227 | ADCT | ADC Therapeutics SA | 480.78M | - | 821,953 | 81.36M |
| 228 | VSTM | Verastem, Inc. | 479.62M | 1.11% | 1,580,248 | 30.91M |
| 229 | OVID | Ovid Therapeutics Inc. | 479.31M | 2.97% | 1,310,528 | 7.25M |
| 230 | CTNM | Contineum Therapeutics, Inc. | 478.65M | 6.48% | 280,243 | - |
| 231 | FULC | Fulcrum Therapeutics, Inc. | 475.10M | -0.28% | 744,018 | 80.00M |
| 232 | IMMX | Immix Biopharma, Inc. | 473.40M | 3.48% | 678,760 | - |
| 233 | RGNX | REGENXBIO Inc. | 463.01M | 6.79% | 525,479 | 170.44M |
| 234 | LYEL | Lyell Immunopharma, Inc. | 460.27M | -4.22% | 51,662 | 36.00K |
| 235 | FDMT | 4D Molecular Therapeutics, Inc. | 452.83M | 0.68% | 740,199 | 85.21M |
| 236 | CADL | Candel Therapeutics, Inc. | 452.67M | - | 1,270,417 | - |
| 237 | AURA | Aura Biosciences, Inc. | 452.61M | 4.75% | 273,677 | - |
| 238 | NMRA | Neumora Therapeutics, Inc. | 451.24M | 9.78% | 1,227,630 | - |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 438.99M | 1.47% | 203,108 | - |
| 240 | ASMB | Assembly Biosciences, Inc. | 428.31M | 2.35% | 56,225 | 72.30M |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | 426.96M | 0.71% | 924,655 | 216.11M |
| 242 | CLYM | Climb Bio, Inc. | 424.18M | 1.14% | 1,011,486 | - |
| 243 | LXEO | Lexeo Therapeutics, Inc. | 421.93M | 0.26% | 393,682 | - |
| 244 | PRTC | PureTech Health plc | 421.78M | -0.86% | 9,042 | 4.66M |
| 245 | LRMR | Larimar Therapeutics, Inc. | 421.76M | -6.45% | 1,484,407 | - |
| 246 | BNTC | Benitec Biopharma Inc. | 412.77M | -0.82% | 106,002 | - |
| 247 | IPSC | Century Therapeutics, Inc. | 412.33M | 4.09% | 522,943 | 109.16M |
| 248 | NGNE | Neurogene Inc. | 407.42M | -1.47% | 107,818 | 925.00K |
| 249 | ENTA | Enanta Pharmaceuticals, Inc. | 403.08M | 0.14% | 162,688 | 66.98M |
| 250 | VTVT | vTv Therapeutics Inc. | 400.08M | 3.10% | 26,239 | 17.00K |
| 251 | IVVD | Invivyd, Inc. | 395.93M | 2.94% | 883,079 | 53.43M |
| 252 | SRZN | Surrozen, Inc. | 383.66M | 5.83% | 81,946 | 3.48M |
| 253 | PBYI | Puma Biotechnology, Inc. | 382.08M | 0.40% | 194,304 | 228.37M |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 379.75M | - | 1,465,104 | - |
| 255 | NAGE | Niagen Bioscience, Inc. | 379.57M | -0.63% | 925,451 | 129.42M |
| 256 | LCTX | Lineage Cell Therapeutics, Inc. | 376.12M | 3.42% | 1,829,573 | 14.56M |
| 257 | AUTL | Autolus Therapeutics plc | 375.26M | - | 710,290 | 75.39M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 370.04M | -0.73% | 287,473 | 35.11M |
| 259 | ARMP | Armata Pharmaceuticals, Inc. | 365.60M | 4.50% | 58,165 | 4.90M |
| 260 | IRD | Opus Genetics, Inc. | 364.87M | 9.42% | 1,436,955 | 14.20M |
| 261 | YDES | YD Bio Limited | 358.63M | -1.73% | 1,131 | 510.36K |
| 262 | AVTX | Avalo Therapeutics, Inc. | 357.97M | 1.52% | 713,667 | 59.00K |
| 263 | MNPR | Monopar Therapeutics Inc. | 349.00M | 4.05% | 81,229 | - |
| 264 | SLN | Silence Therapeutics plc | 345.28M | 2.81% | 123,331 | 559.00K |
| 265 | IMRX | Immuneering Corporation | 339.01M | -0.19% | 762,009 | - |
| 266 | PALI | Palisade Bio, Inc. | 334.85M | 3.63% | 1,860,842 | - |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 332.86M | 5.20% | 177,292 | - |
| 268 | CABA | Cabaletta Bio, Inc. | 332.85M | 7.55% | 1,704,987 | - |
| 269 | RZLT | Rezolute, Inc. | 332.39M | 2.56% | 1,078,836 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 329.02M | -0.21% | 614,465 | 72.59M |
| 271 | GLSI | Greenwich LifeSciences, Inc. | 327.24M | 9.35% | 97,742 | - |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 325.99M | 1.51% | 195,870 | - |
| 273 | IKT | Inhibikase Therapeutics, Inc. | 322.15M | 1.61% | 433,682 | 1.00 |
| 274 | CMPX | Compass Therapeutics, Inc. | 318.76M | 5.99% | 13,524,567 | 850.00K |
| 275 | ABEO | Abeona Therapeutics Inc. | 310.58M | 2.25% | 912,429 | 5.82M |
| 276 | AVXL | Anavex Life Sciences Corp. | 309.52M | 2.45% | 651,097 | - |
| 277 | ACIU | AC Immune SA | 300.58M | 3.41% | 240,868 | 4.51M |
| 278 | NGEN | NervGen Pharma Corp. | 293.78M | -3.20% | 205,849 | - |
| 279 | EDIT | Editas Medicine, Inc. | 293.62M | 6.38% | 1,148,192 | 40.52M |
| 280 | TARA | Protara Therapeutics, Inc. | 288.27M | 3.09% | 640,148 | - |
| 281 | NBP | NovaBridge Biosciences | 285.65M | 5.11% | 3,201,031 | - |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 284.43M | 1.26% | 595,492 | 26.87M |
| 283 | NERV | Minerva Neurosciences, Inc. | 283.66M | 1.25% | 140,228 | - |
| 284 | CLLS | Cellectis S.A. | 283.24M | 4.56% | 12,981 | 79.59M |
| 285 | LENZ | LENZ Therapeutics, Inc. | 281.56M | -0.77% | 844,304 | 19.09M |
| 286 | FHTX | Foghorn Therapeutics Inc. | 278.83M | -0.21% | 118,006 | 30.91M |
| 287 | ELDN | Eledon Pharmaceuticals, Inc. | 276.52M | 8.98% | 1,303,003 | - |
| 288 | CCCC | C4 Therapeutics, Inc. | 276.15M | 10.55% | 2,319,332 | 35.95M |
| 289 | CHRS | Coherus Oncology, Inc. | 273.74M | 2.01% | 523,616 | 42.17M |
| 290 | HELP | Cybin Inc. | 265.69M | 8.15% | 851,808 | - |
| 291 | SABS | SAB Biotherapeutics, Inc. | 262.83M | 7.47% | 651,370 | 114.70K |
| 292 | ALEC | Alector, Inc. | 261.56M | 3.04% | 713,161 | 21.05M |
| 293 | CDXS | Codexis, Inc. | 256.25M | 0.36% | 1,067,370 | 70.39M |
| 294 | ARTV | Artiva Biotherapeutics, Inc. | 253.10M | 17.43% | 271,190 | 251.00K |
| 295 | CGEN | Compugen Ltd. | 251.51M | 2.31% | 345,234 | 72.76M |
| 296 | PLYX | Polaryx Therapeutics, Inc. | 248.55M | 0.57% | 117,785 | - |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 245.01M | 2.62% | 260,297 | 82.03M |
| 298 | ADAG | Adagene Inc. | 243.15M | 3.66% | 68,778 | 7.67M |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 242.04M | 3.70% | 16,618 | 19.39M |
| 300 | ACHV | Achieve Life Sciences, Inc. | 233.72M | 5.78% | 1,507,034 | - |
| 301 | OBIO | Orchestra BioMed Holdings, Inc. | 233.50M | 5.00% | 284,649 | 33.48M |
| 302 | ALXO | ALX Oncology Holdings Inc. | 228.75M | 7.59% | 567,302 | - |
| 303 | NVCT | Nuvectis Pharma, Inc. | 226.77M | 0.71% | 56,368 | - |
| 304 | HRTX | Heron Therapeutics, Inc. | 226.37M | 0.84% | 1,060,531 | 154.90M |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 223.74M | 3.67% | 149,240 | 44.64M |
| 306 | VYGR | Voyager Therapeutics, Inc. | 222.31M | 2.47% | 405,233 | 40.37M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 220.77M | -1.10% | 693,445 | 1.55M |
| 308 | KROS | Keros Therapeutics, Inc. | 220.04M | 0.18% | 266,371 | 244.06M |
| 309 | CNTX | Context Therapeutics Inc. | 216.83M | 0.85% | 624,418 | - |
| 310 | CAMP | Camp4 Therapeutics Corporation | 216.53M | 3.99% | 57,091 | 3.50M |
| 311 | OKUR | OnKure Therapeutics, Inc. | 212.88M | 3.33% | 121,136 | - |
| 312 | REPL | Replimune Group, Inc. | 212.21M | 7.98% | 2,996,248 | - |
| 313 | MDWD | MediWound Ltd. | 212.06M | 1.54% | 53,584 | 16.96M |
| 314 | OABI | OmniAb, Inc. | 201.25M | 2.21% | 700,578 | 18.67M |
| 315 | RNA | Atrium Therapeutics, Inc. | 198.13M | -1.69% | 252,152 | 18.62M |
| 316 | NKTX | Nkarta, Inc. | 197.48M | 2.97% | 652,048 | - |
| 317 | MGNX | MacroGenics, Inc. | 195.77M | 4.76% | 553,839 | 149.50M |
| 318 | ELTX | Elicio Therapeutics, Inc. | 195.37M | 2.91% | 128,147 | - |
| 319 | ENLV | Enlivex Ltd. | 194.61M | 2.28% | 205,194 | - |
| 320 | KRRO | Korro Bio, Inc. | 194.56M | 6.98% | 70,136 | 6.39M |
| 321 | UNCY | Unicycive Therapeutics, Inc. | 193.32M | 6.98% | 657,117 | - |
| 322 | WHWK | Whitehawk Therapeutics, Inc. | 189.26M | -0.74% | 138,757 | 7.15M |
| 323 | KPTI | Karyopharm Therapeutics Inc. | 187.33M | -1.07% | 317,432 | 146.07M |
| 324 | HUMA | Humacyte, Inc. | 186.90M | 2.66% | 2,904,740 | 2.04M |
| 325 | DTIL | Precision BioSciences, Inc. | 184.49M | 3.62% | 227,213 | 34.26M |
| 326 | TNXP | Tonix Pharmaceuticals Holding Corp. | 183.68M | 4.27% | 274,946 | 13.11M |
| 327 | CNTN | Canton Strategic Holdings, Inc. | 183.00M | 3.53% | 482,867 | - |
| 328 | CRBU | Caribou Biosciences, Inc. | 181.68M | -2.08% | 1,024,315 | 11.16M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 175.24M | 0.61% | 332,110 | - |
| 330 | MENS | Jyong Biotech Ltd. | 174.56M | 4.13% | 41,659 | - |
| 331 | PLX | Protalix BioTherapeutics, Inc. | 173.23M | 1.42% | 369,117 | 52.74M |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 172.62M | 2.14% | 236,336 | - |
| 333 | PRQR | ProQR Therapeutics N.V. | 165.42M | 1.95% | 488,728 | 19.19M |
| 334 | RNAC | Cartesian Therapeutics, Inc. | 164.89M | -3.86% | 136,453 | 1.78M |
| 335 | ANTX | AN2 Therapeutics, Inc. | 163.78M | -2.78% | 125,607 | - |
| 336 | TLSA | Tiziana Life Sciences Ltd | 163.36M | 1.59% | 123,096 | - |
| 337 | EDSA | Edesa Biotech, Inc. | 162.39M | 14.94% | 936,197 | - |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 156.93M | 1.04% | 112,698 | 2.00M |
| 339 | KZIA | Kazia Therapeutics Limited | 155.86M | 9.82% | 292,870 | 1.27M |
| 340 | SPRB | Spruce Biosciences, Inc. | 154.89M | 3.24% | 31,630 | 697.00K |
| 341 | MOLN | Molecular Partners AG | 153.58M | -4.94% | 1,519 | 856.30K |
| 342 | BDTX | Black Diamond Therapeutics, Inc. | 151.82M | 3.11% | 569,377 | 70.00M |
| 343 | AGEN | Agenus Inc. | 150.14M | 1.82% | 582,198 | 114.20M |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 149.97M | 4.66% | 4,128,326 | - |
| 345 | ALPS | Alps Group Inc | 149.76M | -3.23% | 68,557 | 3.74M |
| 346 | IFRX | InflaRx N.V. | 149.65M | 4.55% | 1,862,208 | 34.44K |
| 347 | GALT | Galectin Therapeutics Inc. | 149.43M | 0.89% | 301,564 | - |
| 348 | FATE | Fate Therapeutics, Inc. | 145.33M | 0.81% | 743,109 | 6.65M |
| 349 | SPRO | Spero Therapeutics, Inc. | 145.31M | -0.79% | 363,859 | 66.80M |
| 350 | HURA | TuHURA Biosciences, Inc. | 142.42M | 6.67% | 638,186 | - |
| 351 | CNTB | Connect Biopharma Holdings Limited | 139.61M | -2.37% | 102,428 | 64.00K |
| 352 | IPHA | Innate Pharma S.A. | 132.09M | -2.70% | 43,703 | 10.57M |
| 353 | IMUX | Immunic, Inc. | 130.83M | -4.09% | 443,154 | - |
| 354 | ACOG | Alpha Cognition Inc. | 129.99M | 1.70% | 22,707 | 10.22M |
| 355 | EQ | Equillium, Inc. | 128.98M | -1.92% | 168,383 | 4.39M |
| 356 | KLRS | Kalaris Therapeutics, Inc. | 126.56M | 0.18% | 217,172 | - |
| 357 | GNLX | Genelux Corporation | 118.47M | 6.80% | 163,008 | 8.00K |
| 358 | AARD | Aardvark Therapeutics, Inc. | 118.46M | 4.22% | 95,834 | - |
| 359 | CRDF | Cardiff Oncology, Inc. | 118.28M | 6.79% | 715,838 | 593.00K |
| 360 | VANI | Vivani Medical, Inc. | 113.43M | 1.52% | 105,769 | - |
| 361 | PEPG | PepGen Inc. | 113.35M | 5.81% | 432,816 | - |
| 362 | CGTX | Cognition Therapeutics, Inc. | 112.59M | 6.78% | 655,840 | - |
| 363 | NTHI | NeOnc Technologies Holdings, Inc. | 110.11M | 2.79% | 92,563 | 39.99K |
| 364 | SEER | Seer, Inc. | 110.02M | 3.72% | 334,315 | 16.58M |
| 365 | TTRX | Turn Therapeutics Inc. | 109.93M | 3.81% | 15,884 | - |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 109.43M | -3.19% | 27,002 | 35.58M |
| 367 | PYXS | Pyxis Oncology, Inc. | 106.81M | 2.41% | 283,435 | 13.86M |
| 368 | CBUS | Cibus, Inc. | 106.80M | 9.37% | 440,153 | 3.64M |
| 369 | ONCY | Oncolytics Biotech Inc. | 102.19M | 1.03% | 809,161 | - |
| 370 | GUTS | Fractyl Health, Inc. | 101.14M | 5.90% | 1,533,255 | 3.00K |
| 371 | ANIX | Anixa Biosciences, Inc. | 100.58M | 4.17% | 128,865 | - |
| 372 | COYA | Coya Therapeutics, Inc. | 99.22M | 3.93% | 78,396 | 7.95M |
| 373 | PMN | ProMIS Neurosciences, Inc. | 99.00M | -0.99% | 29,301 | - |
| 374 | NRXP | NRx Pharmaceuticals, Inc. | 98.44M | 2.41% | 959,070 | 1.23M |
| 375 | BMEA | Biomea Fusion, Inc. | 98.33M | -6.21% | 2,015,196 | - |
| 376 | KALA | KALA BIO, Inc. | 97.69M | -3.93% | 3,104,306 | - |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 91.77M | - | 532,034 | 65.34K |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 91.48M | 1.33% | 1,179,424 | - |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 88.62M | 1.65% | 387,385 | 1.63M |
| 380 | GOSS | Gossamer Bio, Inc. | 86.32M | 5.21% | 3,457,015 | 48.47M |
| 381 | PYPD | PolyPid Ltd. | 85.87M | -0.66% | 19,036 | - |
| 382 | NRXS | NeurAxis, Inc. | 85.72M | 0.13% | 77,189 | 3.57M |
| 383 | LONA | LeonaBio, Inc. | 85.48M | 3.76% | 15,156 | - |
| 384 | EXOZ | eXoZymes, Inc. | 84.62M | -3.57% | 8,668 | -700.00 |
| 385 | PTHS | Pelthos Therapeutics Inc. | 83.89M | -0.36% | 13,302 | 16.80M |
| 386 | CSBR | Champions Oncology, Inc. | 82.77M | 1.88% | 2,224 | 57.95M |
| 387 | QTTB | Q32 Bio Inc. | 81.92M | 1.82% | 291,778 | 53.74M |
| 388 | OKYO | OKYO Pharma Limited | 81.87M | 2.63% | 23,051 | - |
| 389 | ACET | Adicet Bio, Inc. | 81.16M | -1.05% | 51,459 | - |
| 390 | MAIA | MAIA Biotechnology, Inc. | 80.69M | 2.31% | 557,460 | - |
| 391 | GANX | Gain Therapeutics, Inc. | 79.84M | 7.39% | 476,600 | - |
| 392 | ATYR | aTyr Pharma, Inc. | 79.17M | 5.54% | 752,287 | 190.00K |
| 393 | XBIT | XBiotech Inc. | 78.35M | 1.98% | 41,848 | - |
| 394 | ATHE | Alterity Therapeutics Limited | 78.15M | -0.44% | 16,793 | 4.43M |
| 395 | ICCC | ImmuCell Corporation | 76.54M | 0.24% | 12,865 | 27.64M |
| 396 | PLRX | Pliant Therapeutics, Inc. | 75.54M | 0.83% | 363,604 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 74.13M | - | 95,562 | - |
| 398 | FBIO | Fortress Biotech, Inc. | 74.07M | 3.60% | 195,727 | 63.26M |
| 399 | IBO | Impact BioMedical Inc. | 73.32M | 3.03% | 96,742 | 32.00K |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 71.68M | 2.21% | 357,976 | - |
| 401 | OSTX | OS Therapies Incorporated | 71.47M | 4.29% | 1,220,586 | - |
| 402 | MCRB | Seres Therapeutics, Inc. | 70.65M | 4.54% | 29,986 | 789.00K |
| 403 | FLNA | Filana Therapeutics, Inc. | 70.05M | 0.69% | 572,443 | - |
| 404 | ESLA | Estrella Immunopharma, Inc. | 69.97M | 11.56% | 43,234 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 69.72M | 0.87% | 438,780 | 10.33M |
| 406 | ACTU | Actuate Therapeutics, Inc. | 69.71M | 2.08% | 94,861 | - |
| 407 | MNOV | MediciNova, Inc. | 68.42M | 1.46% | 24,896 | 409.66K |
| 408 | ANVS | Annovis Bio, Inc. | 68.03M | 7.07% | 1,104,533 | - |
| 409 | IMA | ImageneBio, Inc. | 67.33M | 1.52% | 23,301 | 800.00K |
| 410 | IMMP | Immutep Limited | 64.60M | -3.20% | 825,190 | 5.28M |
| 411 | BYSI | BeyondSpring Inc. | 62.51M | 3.41% | 3,857 | 1.88M |
| 412 | IBIO | iBio, Inc. | 61.08M | 4.32% | 2,987,023 | 300.00K |
| 413 | INKT | MiNK Therapeutics, Inc. | 60.58M | 3.30% | 20,623 | - |
| 414 | CING | Cingulate Inc. | 59.89M | 9.34% | 471,386 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 59.10M | - | 87,118 | 20.70M |
| 416 | ENTX | Entera Bio Ltd. | 55.48M | 6.25% | 55,713 | 42.00K |
| 417 | PDSB | PDS Biotechnology Corporation | 54.31M | 1.32% | 529,494 | - |
| 418 | TIL | Instil Bio, Inc. | 54.12M | 1.66% | 10,272 | - |
| 419 | KZR | Kezar Life Sciences, Inc. | 54.00M | 0.14% | 70,220 | - |
| 420 | MGX | Metagenomi Therapeutics, Inc. | 51.92M | 2.22% | 138,709 | 25.21M |
| 421 | SGMO | Sangamo Therapeutics, Inc. | 49.38M | -10.24% | 24,406,073 | 39.55M |
| 422 | RADX | Radiopharm Theranostics Limited | 48.39M | -1.84% | 21,494 | 10.86M |
| 423 | TELO | Telomir Pharmaceuticals, Inc. | 48.13M | -3.45% | 2,589,975 | - |
| 424 | CUE | Cue Biopharma, Inc. | 47.98M | 13.38% | 1,897,280 | 27.47M |
| 425 | DWTX | Dogwood Therapeutics, Inc. | 47.76M | 5.93% | 48,790 | - |
| 426 | RLYB | Rallybio Corporation | 47.50M | 1.13% | 106,830 | 858.00K |
| 427 | NTRB | Nutriband Inc. | 46.98M | 1.98% | 5,829 | 2.28M |
| 428 | ATOS | Atossa Therapeutics, Inc. | 46.24M | 1.70% | 24,716 | - |
| 429 | HYPD | Hyperion DeFi, Inc. | 45.97M | 1.89% | 94,325 | 813.46K |
| 430 | XLO | Xilio Therapeutics, Inc. | 45.80M | 1.67% | 25,593 | 43.77M |
| 431 | MREO | Mereo BioPharma Group plc | 42.84M | -2.89% | 1,011,714 | 500.00K |
| 432 | PSTV | Plus Therapeutics, Inc. | 42.13M | 9.64% | 110,658 | 5.21M |
| 433 | LITS | Lite Strategy, Inc. | 41.82M | - | 162,380 | - |
| 434 | LIXT | Lixte Biotechnology Holdings, Inc. | 40.66M | - | 14,684 | - |
| 435 | PTN | Palatin Technologies, Inc. | 39.98M | -0.30% | 4,146 | 8.96M |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 39.01M | 3.70% | 62,941 | 120.77M |
| 437 | RNXT | RenovoRx, Inc. | 38.29M | 2.27% | 122,836 | 1.12M |
| 438 | INMB | INmune Bio Inc. | 38.02M | 7.52% | 171,806 | 50.00K |
| 439 | RNTX | Rein Therapeutics Inc. | 37.99M | 6.27% | 566,896 | - |
| 440 | ALGS | Aligos Therapeutics, Inc. | 37.06M | 0.34% | 36,903 | 2.19M |
| 441 | EVAX | Evaxion A/S | 36.78M | 3.52% | 17,079 | 7.53M |
| 442 | VERU | Veru Inc. | 36.11M | 0.45% | 33,638 | 16.89M |
| 443 | SNSE | Sensei Biotherapeutics, Inc. | 35.68M | -5.94% | 36,465 | - |
| 444 | PLUR | Pluri Inc. | 34.99M | 1.78% | 1,065 | 1.34M |
| 445 | HOWL | Werewolf Therapeutics, Inc. | 34.97M | 5.82% | 530,339 | 1.14M |
| 446 | GRCE | Grace Therapeutics, Inc. | 34.66M | 6.67% | 765,245 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 34.61M | -5.13% | 126,745 | 90.00K |
| 448 | CRVO | CervoMed Inc. | 34.16M | 1.10% | 25,092 | 4.01M |
| 449 | QNTM | Quantum BioPharma Ltd. | 33.40M | 1.42% | 487,850 | - |
| 450 | DARE | Daré Bioscience, Inc. | 33.20M | 8.57% | 238,083 | 1.03M |
| 451 | NXTC | NextCure, Inc. | 32.79M | 3.02% | 54,247 | - |
| 452 | BOLD | Boundless Bio, Inc. | 32.71M | 0.69% | 73,686 | - |
| 453 | IGC | IGC Pharma, Inc. | 31.58M | 3.16% | 331,418 | 1.11M |
| 454 | SKYE | Skye Bioscience, Inc. | 30.87M | -1.71% | 61,240 | - |
| 455 | BCTX | BriaCell Therapeutics Corp. | 30.36M | 3.98% | 97,677 | - |
| 456 | PLRZ | Polyrizon Ltd. | 29.76M | 1.15% | 38,877 | - |
| 457 | TVRD | Tvardi Therapeutics, Inc. | 29.55M | 2.94% | 38,249 | - |
| 458 | KYNB | Kyntra Bio, Inc. | 29.42M | 3.12% | 6,336 | 6.44M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 29.02M | 2.23% | 245,491 | - |
| 460 | SNTI | Senti Biosciences Holdings, Inc. | 28.81M | -5.99% | 225,094 | 22.00K |
| 461 | DYAI | Dyadic International, Inc. | 28.59M | 3.54% | 4,088 | 3.09M |
| 462 | APLM | Apollomics, Inc. | 28.55M | -0.61% | 1,764 | 8.84M |
| 463 | TPST | Tempest Therapeutics, Inc. | 28.54M | 14.37% | 416,421 | - |
| 464 | NEUP | Neuphoria Therapeutics Inc. | 28.41M | 1.54% | 29,003 | 14.99M |
| 465 | LSTA | Lisata Therapeutics, Inc. | 28.18M | -3.11% | 14,873 | 170.00K |
| 466 | TVGN | Tevogen Bio Holdings Inc. | 27.65M | 3.43% | 7,431 | - |
| 467 | CELU | Celularity Inc. | 26.94M | -2.68% | 57,897 | 40.58M |
| 468 | NNVC | NanoViricides, Inc. | 26.78M | 1.64% | 97,886 | - |
| 469 | BRNS | Barinthus Biotherapeutics plc | 26.55M | 8.35% | 28,352 | 14.97M |
| 470 | JSPR | Jasper Therapeutics, Inc. | 26.21M | 5.13% | 112,795 | - |
| 471 | OTLK | Outlook Therapeutics, Inc. | 26.15M | -2.50% | 3,893,490 | 205.70K |
| 472 | ABVC | ABVC BioPharma, Inc. | 25.45M | - | 54,680 | 797.92K |
| 473 | LGVN | Longeveron Inc. | 24.90M | -1.74% | 269,658 | 1.20M |
| 474 | CVM | CEL-SCI Corporation | 24.85M | 5.50% | 46,976 | - |
| 475 | MRKR | Marker Therapeutics, Inc. | 24.34M | 0.69% | 37,888 | 3.55M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 24.30M | 2.94% | 225,584 | 789.00K |
| 477 | CRIS | Curis, Inc. | 23.99M | 6.88% | 371,537 | 9.44M |
| 478 | AEON | AEON Biopharma, Inc. | 23.35M | -3.32% | 69,784 | - |
| 479 | OSRH | OSR Holdings, Inc. | 23.28M | 52.80% | 292,265,413 | 2.91M |
| 480 | LTRN | Lantern Pharma Inc. | 22.98M | 3.54% | 183,456 | - |
| 481 | SER | Serina Therapeutics, Inc. | 22.41M | -0.55% | 37,768 | 130.00K |
| 482 | XCUR | Exicure, Inc. | 21.42M | 1.51% | 5,284 | 500.00K |
| 483 | ALLR | Allarity Therapeutics, Inc. | 21.36M | -2.17% | 93,918 | 320.00K |
| 484 | QNCX | Quince Therapeutics, Inc. | 21.35M | 6.50% | 654,870 | - |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.22M | 0.13% | 37,564 | 570.00K |
| 486 | CVKD | Cadrenal Therapeutics, Inc. | 20.53M | 19.32% | 114,292 | - |
| 487 | NCEL | NewcelX Ltd. | 20.10M | 28.95% | 181,389 | - |
| 488 | COCP | Cocrystal Pharma, Inc. | 19.71M | 2.88% | 138,930 | - |
| 489 | LPCN | Lipocine Inc. | 18.70M | 1.75% | 138,841 | 1.98M |
| 490 | KTTA | Pasithea Therapeutics Corp. | 17.33M | 0.87% | 228,513 | - |
| 491 | GNTA | Genenta Science S.p.A. | 16.78M | 0.88% | 55,941 | - |
| 492 | ICU | SeaStar Medical Holding Corporation | 16.53M | 6.98% | 50,110 | 1.23M |
| 493 | TOVX | Theriva Biologics, Inc. | 16.46M | 8.67% | 2,648,983 | - |
| 494 | PASG | Passage Bio, Inc. | 16.39M | -4.49% | 72,266 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 16.33M | -4.34% | 325,883 | 368.00K |
| 496 | CTXR | Citius Pharmaceuticals, Inc. | 15.57M | 16.96% | 1,478,911 | 3.94M |
| 497 | PBM | Psyence Biomedical Ltd. | 15.11M | 29.72% | 669,015 | - |
| 498 | TRAW | Traws Pharma, Inc. | 14.52M | 10.00% | 283,050 | 2.79M |
| 499 | INAB | IN8bio, Inc. | 14.48M | -2.65% | 66,406 | - |
| 500 | HOTH | Hoth Therapeutics, Inc. | 14.27M | 4.42% | 292,570 | - |